Merck Says Its Covid Pill Is Less Effective in a Final Analysis https://ift.tt/eA8V8J

The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.

from NYT > Top Stories https://ift.tt/3p2BTlU
November 27, 2021 at 12:32AM